[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

BELL et al., 1976 - Google Patents

Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients

BELL et al., 1976

View PDF
Document ID
13366325003007606363
Author
BELL W
TOMASULO P
ALVING B
DUFFY T
Publication year
Publication venue
Annals of Internal Medicine

External Links

Snippet

In a group of 52 patients receiving continuous intravenous heparin, 16 developed thrombocytopenia (platelets< 100 000/mm3). Ten of the 16 patients who had thrombocytopenia had elevated titers of fibrinogen-fibrin degradation products, and five of …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material

Similar Documents

Publication Publication Date Title
BELL et al. Thrombocytopenia occurring during the administration of heparin: a prospective study in 52 patients
Spaet et al. Defective platelets in essential thrombocythemia
Clemens et al. Activation of the coagulation cascade in severe falciparum malaria through the intrinsic pathway
Tait et al. Influence of demographic factors on antithrombin III activity in a healthy population
WO2002079375A1 (en) Rapid assessment of coagulation activity in whole blood
US3985618A (en) Method for detection of thrombosis and prethrombosis
Schwartz et al. Complications of heparin administration in normal individuals
Kario et al. Imbalance between thrombin and plasmin activity in disseminated intravascular coagulation
Bjurö et al. Observations on histamine in pregnancy and the puerperium
HOLM et al. The antithrombotic effect of heparin in deep venous thrombosis: relation to four heparin assays
Duffy et al. Multistate outbreak of hemolysis in hemodialysis patients traced to faulty blood tubing sets
O'driscoll et al. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion
ALEXANDER et al. A guide to anticoagulant therapy
Bucher et al. Clinical indicators of envenoming and serum levels of venom antigens in patients bitten by Bothrops lanceolatus in Martinique
Crisnic et al. Disseminated intravascular coagulation and acute renal failure
Bowman Acquired fibrinogenopenia
Colvin Management of disseminated intravascular coagulation.
McMillan et al. Acquired coagulation disorders in children
Riaz et al. Assessment of anaemia in children with juvenile idiopathic arthritis and its relationship with disease activity and disease duration
Straub et al. Recurrent intravascular coagulation with renal cortical necrosis and recovery
Lopas et al. Experimental transfusion reactions and disseminated intravascular coagulation produced by incompatible plasma in monkeys
Greenberg et al. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants
Preston et al. Serial changes in the coagulation system following clotting factor concentrate infusion
LEE et al. Acquired inhibitor of blood coagulation
Boyd et al. Sampling for international normalized ratios in patients on hemodialysis with central venous catheters